Skip to main content
The American Journal of Clinical Nutrition logoLink to The American Journal of Clinical Nutrition
. 2009 Jul 8;90(3):570–577. doi: 10.3945/ajcn.2008.27199

Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma123

Dominique S Michaud , Crystal N Holick, Tracy T Batchelor, Edward Giovannucci, David J Hunter
PMCID: PMC2728643  PMID: 19587083

Abstract

Background: The hypothesis that nitrosamine exposure may increase the risk of glioma has been circulating for several decades, but testing it has been difficult because of the ubiquitous nature of nitrosamine exposure. Diet has been the focus of many studies because it can substantially influence nitrosamine exposure, mostly from the endogenous formation of nitrosamines based on intake of nitrite and nitrate.

Objective: The objective was to examine the relation between intakes of meats, nitrate, nitrite, and 2 nitrosamines [nitrosodimethylamine (NDMA) and nitrosopyrolidine (NPYR)] and glioma risk in a prospective analysis.

Methods: Data from 3 US prospective cohort studies were combined for this analysis; 335 glioma cases were diagnosed during ≤24 y of follow-up. Dietary intake was assessed with food-frequency questionnaires. Nitrate, nitrite, and nitrosamine values were calculated based on published values of these nutrients in various foods over different periods in time. Cox proportional hazards models were used to estimate incidence rate ratios (RRs) and 95% CIs. Estimates from each cohort were pooled by using a random-effects model.

Results: Risk of glioma was not elevated among individuals in the highest intake category of total processed meats (RR: 0.92; 95% CI: 0.48, 1.77), nitrate (RR: 1.02; 95% CI: 0.66, 1.58), nitrites (RR: 1.26; 95% CI: 0.89, 1.79), or NDMA (RR: 0.88; 95% CI: 0.57, 1.36) compared with the lowest category. No effect modification was observed by intake of vitamins C or E or other antioxidant measures.

Conclusion: We found no suggestion that intake of meat, nitrate, nitrite, or nitrosamines is related to the risk of glioma.

INTRODUCTION

N-Nitroso compounds (NOC) are broadly acting and potent carcinogens in animal models (1, 2). Furthermore, transplacental exposure to ethylnitrosourea (ENU)—a nitrosamide—results in the formation of brain tumors, including gliomas, in rodents (3). NOC can be present in food treated with sodium nitrite or can form endogenously if the nitrites react with secondary amines or amides (1). The endogenous formation of NOCs in the stomach is complex because it is influenced by various physiologic parameters, including gastric pH, the presence of bacteria, and antioxidants (4). NOCs have been detected in brain tissue and can cross the blood-brain barrier (5). Processed and cured meat intakes have been used as markers of NOC exposure. Because they contain high concentrations of nitrites and are often eaten on a daily basis, their total contribution to the overall level of NOCs can be substantial.

Many positive findings from studies examining the association between maternal intake of cured meats during pregnancy and the subsequent risk of childhood cancer (6) have provided incentive to examine these dietary exposures in relation to adult brain tumors. To date, findings from studies on dietary intake of meats, particularly processed meats, and the risk of adult gliomas have been inconsistent. However, a meta-analysis of 9 observational studies, mostly case-control studies, suggested that a positive association may exist [relative risk (RR): 1.48; 95% CI: 1.20, 1.83] for adult glioma among individuals with a high cured meat intake of all types, although total energy was not adjusted for in most studies (7). To our knowledge, only one prospective study has addressed this hypothesis to date, and only 21 glioma cases were included in that analysis (8).

This study was undertaken to examine the association between intake of total meat, processed meats, nitrosamine precursors (ie, nitrate, nitrite), and 2 nitrosamines [nitrosodimethylamine (NDMA) and nitrosopyrolidine (NPYR)] and the risk of glioma in 3 US prospective cohort studies.

SUBJECTS AND METHODS

Study populations

The Nurses’ Health Study I (NHS I) was initiated in 1976, when 121,700 registered US female nurses aged 30–55 y returned a mailed questionnaire that assessed information on lifestyle factors, medical histories, and smoking histories (9). Similarly, the Health Professionals Follow-Up Study (HPFS) is a cohort of 51,529 US male physicians, dentists, optometrists, osteopaths, podiatrists, pharmacists, and veterinarians who were 40–75 y of age at enrollment in 1986 (10). The study design and methods of dietary assessment and follow-up for the Nurses’ Health Study II (NHS II) are very similar to those of NHS I. In 1989, 116,686 women aged 25–42 y and living in 14 US states were enrolled in NHS II (11). Follow-up questionnaires are mailed biennially to all cohort members to update information on lifestyle factors, diet, and newly diagnosed medical conditions. The questionnaire response rate over the period of follow-up was 94% among women in the NHS I diet cohort (1980–2002) and was 92% among men in the HPFS (1986–2002). The follow-up rate for the cohorts for incidence of cancer was >95% of the total possible person-years.

Deaths of cohort members are frequently reported by family members or by the postal service in response to questionnaire mailings. In addition, the National Death Index is searched biennially for nonrespondents; this method has been shown to have a sensitivity of 98% (12). This study was approved by the Human Research Committee of the Brigham and Women’s Hospital.

Dietary assessment

To assess dietary intake, food-frequency questionnaires (FFQs) were initially collected in 1986 for 49,935 men (HPFS), in 1980 for 92,468 women (NHS I), and in 1991 for 95,391 women (NHS II), and diet was generally updated every 4 y. For the NHS I, we used a 61-item semiquantitative FFQ (including dietary items and vitamin use) at baseline in 1980, which was expanded to ≈130 items (including food, beverages, and vitamin use) in 1984, 1986, and every 4 y thereafter. For the HPFS and NHS II cohorts, baseline dietary intake was assessed by using a 131-item FFQ. The questions on meat intake (other than fish) were very similar on the 61-item FFQs and the 131-item FFQs; both had the same number of questions with similar meat items included in each.

For each item, participants were asked to report their average use over the preceding year for a specified serving size of each food and beverage. Nine prespecified frequency responses were possible, ranging from never or almost never to ≥6 times/d. Individual nutrient intakes were calculated by multiplying the frequency of each food or beverage consumed by the nutrient content of the specified portion size and then by summing the contributions from all foods and beverages. Food composition data were primarily based on values obtained from the US Department of Agriculture supplemented with our own data. For vitamins C and E, calculations were based on dietary intake and vitamin supplement use (current use and dose of vitamin supplements and the brand and type of multivitamins). We also estimated the ferric-reducing ability of plasma (FRAP) using dietary intake to represent the total antioxidant capacity of foods. The FRAP assay measures the reduction of Fe3+ (ferric ion) to Fe2+ (ferrous ion) in the presence of antioxidants and expresses the corresponding concentration of hydrogen- or electron-donating antioxidants (13, 14). Data on FRAP from plant foods were gathered from published databases.

In addition, we searched the literature for publications with food values for nitrate, nitrite, NDMA, and NPYR and derived a database with values for these compounds for each of the cohort baseline FFQs, accounting for changes in values over time due to changes in processing practices to lower nitrosamine concentrations (1539). To calculate these compounds, we first considered publications in which measurements in foods were made closest in time to the questionnaire year and preferably in the United States. If food values were not available from that time period or from the United States, we used measurements made in foods at different times or from Europe. For foods with more than one available measurement (from one or more publications), we estimated the weighted average value of the compounds (based on number of food samples tested) and used those values for our calculations.

Intakes of meat were calculated by multiplying the frequency of intake for individual items by their weights, which were estimated from the specified portion size (and by using additional data from the validation studies to determine mean values for portion size to verify that the specified sizes were accurate). Total meat consisted of the following food items: processed meats (eg, sausage, salami, and bologna); bacon; hot dogs; hamburger; beef, pork, or lamb in a sandwich or mixed dish; beef, pork, or lamb as a main dish; chicken or turkey with skin; and chicken or turkey without skin. Red meat consisted of total meat minus chicken or turkey. Total processed meats consisted of the processed meat item (eg, sausage, salami, and bologna) plus bacon and hot dogs.

The reproducibility and validity of food and beverage intake were described previously for the HPFS (40, 41) and NHS I (42). In the HPFS, Pearson correlations between the average intake assessed by two 1-wk diet records completed 6 mo apart, and the FFQ ranged from 0.56 for chicken or turkey without skin to 0.83 for processed meat (40). In NHS I, the correlations between the diet records (corrected for within-person variation) and FFQ were 0.70 for bacon, 0.56 for hot dogs, 0.55 for processed meats, 0.46 for meat (from a main dish or mixed dish), and 0.38 for hamburgers (42). Vitamin E intake was positively correlated with its plasma concentrations in women (r = 0.41) (43). Correlation coefficients between intakes from the FFQs and the average of two to four 1-wk diet records for vitamin C was 0.75 in women (44) and 0.92 for both total vitamins C and E in men (41).

Case ascertainment

On each biennial questionnaire, the participants were asked whether they had received a diagnosis of cancer, heart disease, or other medical conditions during the previous 2 y. When permission was received from the cases (or next of kin for decedents), medical records and pathology reports were obtained from hospitals and reviewed by study investigators, who were blinded to the questionnaire data. Nonrespondents were telephoned in an attempt to confirm the initial cancer report and date of diagnosis. Medical records and pathology reports were requested for reported and deceased glioma cases; ≈88% of potential cases (ie, self-reported or deceased cases with glioma) were subsequently confirmed with medical, pathology, or cancer registry data. When we were unable to obtain records, we attempted to corroborate diagnoses of glioma with additional information from the participant or next of kin. We only included glioma cases for which a medical, pathology, or death record or other confirmation of the cancer was obtained. We included all glioma brain tumors; these included astrocytoma [ (ICD-O) codes 9400, 9401, and 9411 (45)], glioblastoma (9440, 9441, and 9442/3), oligodendroglioma (9450, 9451, and 9460), ependymoma (9391, 9392, 9393, and 9394), mixed glioma subtypes (9382), and glioma, NOS (9380).

We identified 133 newly diagnosed gliomas between 1986 and 2004 among men, 182 gliomas among women in the NHS I between 1980 and 2004, and 20 gliomas among women in the NHS II between 1991 and 2005.

Statistical analysis

Person-time of follow-up was calculated from the date for return of the baseline FFQ (1980 for NHS I, 1986 for HPFS, and 1991 for NHS II) until the date of glioma diagnosis, date of death from any cause, or the end of follow-up (31 December 2004 for HPFS, 31 May 2004 for NHS I, and 31 May 2005 for NHS II), whichever came first. We excluded participants who reported a history of cancer other than nonmelanoma skin cancer at baseline or those with implausibly high or low daily caloric intakes (<800 or >4200 kcal/d for men; <500 or >3500 kcal/d for women). After these exclusions (which takes care of poor responders), any individual dietary questionnaire item that was missing an entry was coded as not being consumed by participant (because our validation studies have confirmed that most foods with missing responses on the FFQ are not consumed by the participants). Consequently there were no missing values for the estimated nutrients and vitamins. Missing values for the individual meat items ranged between 0.70% and 2.9% in the HPFS and between 0.3% and 1.0% in the NHS. The cohorts for analyses included 47,897 (96%) men in the HPFS followed for up to 18 y, 88,795 (96%) women in the NHS I who were followed for up to 24 y, and 93,963 (99%) women in the NHS II who were followed for up to 14 y.

Cox proportional hazards models for failure-time data were used to estimate the incidence rate ratio (RR) and 95% CI for glioma risk and to adjust for potential confounders. All models were stratified by age (continuous in months) and calendar year. In addition, we included total caloric intake in all models because it minimizes extraneous variation introduced by underreporting or overreporting in the FFQ (46). Additional analyses were conducted to check for potential confounding by total (dietary and supplement) vitamins C or E intakes (quintiles) and combined coffee and tea intake (categories: <2, 2, 3, 4, and >4 cups/d, given an association for this variable in these cohorts; 1 cup = 237 mL). Other factors typically considered as potential confounders in cancer analyses (eg, smoking, BMI, and fruit and vegetables) were not included in the models because they are not risk factors for glioma in these cohorts (47, 48). Furthermore, social class and education are fairly homogeneous in these cohorts because they are all health professionals.

For the meat analyses, we conducted baseline analyses (based on baseline FFQs) and updated dietary intakes with diet from subsequent questionnaires (in 1984, 1986, 1990, 1994, 1998, and 2002 in NHS I; in 1990, 1994, 1998, and 2002 in HPFS; and in 1995, 1999, and 2003 in NHS II). In these analyses, we assessed glioma risk in relation to the cumulative average of diet calculated from all of the preceding dietary questionnaires. The use of cumulative averages may reduce within-person subject variation and better represent long-term average intake (49). For example in the HPFS, dietary data from the 1986 FFQ was used for follow-up from 1986 to 1990, the average dietary intake from the 1986 and 1990 FFQs was used for follow-up from 1990 to 1994, and so forth. Because nitrite and nitrosamine databases were only created for the baseline questionnaires, we did not conduct updated analyses for the nutrients.

Tests of linear trend were conducted by assigning the median values for each and treating those as a single continuous variable with Cox proportional hazards regression. Because of the small number of glioma cases observed in the NHS II, the NHS I and NHS II cohorts were combined; the results in the women reflect the pooled estimates of the 2 cohorts. Quintiles for groups of foods or nutrients were created based on their distribution in each cohort study before the results were pooled; therefore, cutoffs vary by cohort. For bacon and hot dogs, the categories were based on the intake categories provided on the FFQs. Before pooling with the use of meta-analysis, tests of heterogeneity of the main exposures by cohort were performed by using the Q statistic, and data were pooled by using a random-effects model for the log of the RR (50); no statistically significant heterogeneity was observed unless noted otherwise. All reported P values are 2-tailed. All of the statistical procedures were performed by using SAS version 8 (SAS Institute Inc, Cary, NC).

RESULTS

In all 3 cohorts, individuals with the highest intake of processed meat had elevated intakes of nitrite and nitrosamines and lower intakes of vitamin C, vitamin E, and folate compared with those in the lowest category of processed meat intake (Table 1). Men and women who had higher intakes of processed meats were more likely to be current smokers than were those who had lower intakes. Coffee and alcohol intakes were positively associated with processed meat intake in the HPFS and NHS I cohorts, but not in the NHS II cohort. Age, height, and BMI did not vary appreciably across categories of processed meat consumption in all 3 cohorts, although there were small differences that were statistically significant.

TABLE 1.

Baseline characteristics by processed meat intake among men in the Health Professionals Follow-Up Study (HPFS; 1986) and women in the Nurses’ Health Study I (NHS I; 1980) and NHS II (1991)1

Processed meats (quintile)2
Men, HPFS
Women, NHS I
Women, NHS II
Characteristic 1 3 5 1 3 5 1 3 5
No. of individuals 8641 10,880 8889 8989 21,757 22,385 17,961 20,502 18,556
Processed meats (g/d) 0.14 ± 0.33 5.9 ± 1.0 27 ± 13.6 0 ± 0 5.2 ± 1.0 23 ± 12 0 ± 0 4.7 ± 0.7 18 ± 9.2
Age (y) 56 ± 9.9 54 ± 9.8 54 ± 9.5 49 ± 7.0 47 ± 7.2 46 ± 7.1 37 ± 4.6 37 ± 4.7 36 ± 4.6
Height (in)4 70 ± 2.7 70 ± 2.7 70 ± 2.7 64 ± 3.2 64 ± 3.4 64 ± 3.2 65 ± 2.6 65 ± 2.6 65 ± 2.6
BMI (kg/m2) 25 ± 2.9 26 ± 3.1 26 ± 3.4 24 ± 4.1 24 ± 4.2 25 ± 4.7 24 ± 4.6 25 ± 5.3 26 ± 6.0
Past smoker (%) 42 45 44 33 28 25 25 21 20
Current smoker (%) 5 9 15 22 29 32 9 12 15
Pack-years of cigarettes5 23 25 28 45 41 41 11 12 13
Daily dietary intake
 NDMA (μg) 0.06 ± 0.04 0.07 ± 0.04 0.09 ± 0.05 0.09 ± 0.22 0.11 ± 0.26 0.11 ± 0.24 0.06 ± 0.03 0.06 ± 0.02 0.07 ± 0.02
 NPYR (μg) 0.01 ± 0.007 0.03 ± 0.03 0.07 ± 0.09 0.01 ± 0.002 0.02 ± 0.02 0.05 ± 0.06 0.01 ± 0.002 0.02 ± 0.01 0.04 ± 0.05
 Nitrite (mg) 1.6 ± 0.4 1.6 ± 0.3 2.1 ± 0.6 1.4 ± 0.4 1.3 ± 0.4 1.6 ± 0.4 1.9 ± 0.5 2.0 ± 0.4 2.4 ± 0.5
 Nitrate (mg) 183 ± 122 150 ± 84 139 ± 84 127 ± 106 96 ± 76 86 ± 65 172 ± 112 137 ± 81 125 ± 73
 Total meat (g/d) 89 ± 61 118 ± 59 166 ± 66 107 ± 68 123 ± 60 163 ± 67 83 ± 83 117 ± 52 153 ± 60
 Coffee (cups)6 0.9 ± 1.4 1.3 ± 1.6 1.6 ± 1.7 1.9 ± 2.0 2.3 ± 2.0 2.4 ± 2.1 1.2 ± 1.5 1.3 ± 1.6 1.3 ± 1.7
 Alcohol (g) 8.6 ± 13.1 11 ± 15 13.7 ± 18 5.5 ± 9.7 6.6 ± 11 6.3 ± 11 3.0 ± 5.7 3.1 ± 6.0 3.1 ± 6.3
 Fruit and vegetables (serving) 6.8 ± 3.8 5.5 ± 2.9 5.6 ± 2.8 4.7 ± 2.5 3.9 ± 2.1 4.0 ± 2.0 5.6 ± 3.3 4.9 ± 2.8 5.2 ± 2.7
 Vitamin C (mg)7 572 ± 580 407 ± 447 332 ± 360 467 ± 766 301 ± 495 250 ± 428 345 ± 438 238 ± 284 208 ± 230
 Vitamin E (mg)7 70 ± 115 48 ± 89 38 ± 71 59 ± 135 35 ± 97 27 ± 79 35 ± 81 23 ± 53 20 ± 44
 Folate (μg)7 564 ± 332 473 ± 268 423 ± 220 445 ± 321 367 ± 275 329 ± 240 554 ± 332 465 ± 282 428 ± 254
 Multivitamin use (%) 68 61 59 41 34 32 49 43 42
1

All variables (except age) are age-standardized. NDMA, nitrosodimethylamine; NPYR, nitrosopyrolidine.

2

< 0.001 for linear trend across categories for all variables (in each cohort) by using generalized linear models for continuous variables, Similarly, for categorical variables, P < 0.001 for all variables by using chi-square tests.

3

Mean ± SD (all such values).

4

1 inch = 2.54 cm.

5

Among past and current smokers.

6

1 cup = 237 mL.

7

Energy-adjusted nutrient intake from diet and vitamin supplement.

We examined total meat intake and different processed meats in relation to glioma risk in each cohort separately but present only pooled results because there was no heterogeneity across the cohorts (Table 2 and Table 3). No associations were observed for total meat, red meat, processed meat, bacon, or hot dogs and risk of glioma in these cohorts. The analyses were similar when using baseline diet (data not shown) and when modeling the cumulative average for meat intake over the follow-up years in each cohort (Tables 2 and 3). All models included age and calories; other covariates, including intakes of vitamins C and E and coffee/tea did not modify the associations (<10% change in RR).

TABLE 2.

Total meat, red meat, and total processed meat intakes and the risk of glioma in the Health Professionals Follow-Up Study (HPFS; 1986–2004), Nurses’ Health Study I (NHS I; 1980–2004), and NHS II (1991–2005)

Quintile of intake
1 2 3 4 5 P for trend1
Total meat2
 Cases 82 66 55 68 64
 Person-years 810,691 826,958 835,781 835,382 792,300
 RR (95% CI)3 1.0 0.71 (0.51, 0.99) 0.66 (0.43, 1.01) 0.88 (0.63, 1.24) 0.81 (0.55, 1.19) 0.65
Red meat2
 Cases 76 68 66 62 63
 Person-years 806,694 833,135 834,460 831,669 794,937
 RR (95% CI)3 1.0 1.12 (0.81, 1.54) 0.96 (0.68, 1.36) 0.93 (0.64, 1.34) 1.09 (0.62, 1.93) 0.57
Total processed meat2
 Cases 46 69 85 70 65
 Person-years 545,587 831,353 929,827 903,604 890,740
 RR (95% CI)3 1.0 1.11 (0.75, 1.63) 1.14 (0.77, 1.69) 1.17 (0.79, 1.73) 0.92 (0.48, 1.77) 0.99
1

Based on the median value of each intake category and modeling these as continuous variables in a Cox proportional hazards model.

2

Total meat consists of all meats except fish; red meat consists of total meat less chicken and turkey; total processed meat consists of processed meat items (eg, salami and sausage), bacon, and hot dogs. Cutoffs for quintiles were different for each cohort and are based on cumulative updated averages (g/d) over the follow-up periods: total meat (HPFS: 75, 102, 130, and 166; NHS I: 80, 119, 133, and 161; NHS II: 83, 110, 135, and 171), red meat (HPFS: 29, 51, 77, and 111; NHS I: 29, 43, 60, and 79; NHS II: 34, 52, 70, and 102), and total processed meats (HPFS: 1.8, 4.4, 7.6, and 13.9; NHS I: 1.3, 3.9, 7.1, and 12.4; NHS II: 2.1, 4.7, 7.8, and 13.2).

3

Rate ratios (RRs) and 95% CIs from Cox proportional hazards models were adjusted for age and caloric intake (quintiles). Results were obtained from pooling the β coefficient and SE estimates by using the DerSimonian and Laird random-effects model; no significant evidence of heterogeneity by cohort was observed (α = 0.05).

TABLE 3.

Bacon and hot dog intakes and the risk of glioma in the Health Professionals Follow-Up Study (HPFS; 1986–2004), Nurses’ Health Study I (NHS I; 1980–2004), and NHS II (1991–2005)

Categories of intake
0 1–3 servings/mo 1 serving/wk >1 serving/wk P for trend1
Bacon
 Cases 118 111 61 45
 Person-years 1,427,325 1,409,855 839,244 424,689
 RR (95% CI)2 1.0 1.02 (0.79, 1.33) 0.82 (0.58, 1.16) 1.02 (0.72, 1.46) 0.51
Hot dogs
 Cases 79 157 73 26
 Person-years 1,153,413 1,725,418 968,318 253,963
 RR (95% CI)2 1.0 1.23 (0.93, 1.63) 1.17 (0.83, 1.65) 1.13 (0.70, 1.82) 0.73
1

Based on the median value of each intake category and modeling these as continuous variables in a Cox proportional hazards model.

2

Rate ratios (RRs) and 95% CIs from Cox proportional hazards models were adjusted for age and caloric intake (quintiles). Results were obtained from pooling the β coefficient and SE estimates by using the DerSimonian and Laird random-effects model; no significant evidence of heterogeneity by cohort was observed (α = 0.05).

To explore the possibility that dietary nitrosamines (preformed) and nitrosamine precursors (ie, nitrates and nitrites) might be related to risk of glioma, we examined associations with nitrate, nitrites, and 2 common dietary nitrosamines (NDMA and NPYR). The estimated NDMA concentrations were higher in the NHS I cohort because beer still contained NDMA in 1980 (baseline diet); NDMA concentrations in beer were lower in the early 1980s as a result of changes in beer processing. Main dietary contributors to nitrate intake were green-leafy vegetables; for nitrites, skim milk, orange juice, processed meats, and hot dogs were the top contributors; for NDMA, beer in the NHS I (1980) and skim milk in HPFS (1986) were the main sources; for NPYR, bacon was the main contributor. For these analyses, we observed no relation between nitrate, nitrites, NDMA, or NPYR intakes and the risk of glioma in the individual cohorts (data not shown) or when pooling the cohorts (Table 4).

TABLE 4.

Nitrate, nitrite, nitrosodimethylamine (NDMA), and nitrosopyrolidine (NPYR) intakes and the risk of glioma in the Health Professionals Follow-Up Study (HPFS; 1986–2004), Nurses’ Health Study I (NHS I; 1980–2004), and NHS II (1991–2005)

Quintile of intake
1 2 3 4 5 P for trend1
Nitrate2
 Cases 67 74 60 59 75
 Person-years 815,155 833,168 811,541 822,304 818,945
 RR (95% CI)3 1.0 1.06 (0.76, 1.48) 0.84 (0.57, 1.22) 0.95 (0.46, 1.98) 1.02 (0.66, 1.58) 0.81
Nitrite2
 Cases 55 65 71 69 75
 Person-years 812,763 812,974 844,064 810,417 820,895
 RR (95% CI)3 1.0 1.11 (0.72, 1.71) 1.20 (0.84, 1.71) 1.14 (0.73, 1.78) 1.26 (0.89, 1.79) 0.23
NDMA2
 Cases 69 80 59 67 60
 Person-years 794,817 1,012,119 672,847 888,972 732,359
 RR (95% CI)3 1.0 0.95 (0.68, 1.33) 0.91 (0.64, 1.30) 0.94 (0.66, 1.32) 0.88 (0.57, 1.36) 0.73
NPYR4
 Cases 193 58 84
 Person-years 2,244,720 968,505 887,888
 RR (95% CI)3 1.0 0.81 (0.52, 1.20) 0.81 (0.62, 1.05) 0.93
1

Based on the median value of each intake category and modeling these as continuous variables in a Cox proportional hazards model.

2

Cutoffs for quintiles were different for each cohort and are based on baseline values: nitrate (HPFS: 87, 120, 155, and 205; NHS I: 43, 56, 87, and 145; NHS II: 78, 108, 141, and 190), nitrite (HPFS: 1.4, 1.6, 1.8, and 2.0; NHS I: 1.1, 1.3, 1.5, and 1.7; NHS II: 1.7, 1.9, 2.1, and 2.4), and NDMA (HPFS: 0.04, 0.05, 0.07, and 0.09; NHS I: 0.02, 0.04, 0.05, and 0.09; NHS II: 0.04, 0.05, 0.06, and 0.08).

3

Rate ratios (RRs) and 95% CIs from Cox proportional hazards models were adjusted for age and caloric intake (quintiles). Results were obtained from pooling the β coefficient and SE estimates by using the DerSimonian and Laird random-effects model; no significant evidence of heterogeneity by cohort was observed (α = 0.05).

4

Because of the limited range of intakes, it was not possible to create quintiles. Cutoffs are for the following tertiles: HPFS (0.01 and 0.03), NHS I (0.01 and 0.02), and NHS II (0.01 and 0.02).

Because antioxidants can influence the formation of nitrosamines in the stomach, the association between processed meat and glioma may be modified by dietary vitamin intakes. To address this possibility, we first examined whether vitamins C and E and FRAP, an indicator of total antioxidant capacity, were related to risk of glioma overall. No associations were noted for these exposures in all 3 cohorts; pooled results are shown in Table 5. Furthermore, no interactions were observed between intakes of total processed meat and vitamins C and E and FRAP in a comparison of high meat and low antioxidant intakes with low meat and high antioxidant intakes (data not shown; all P values >0.3).

TABLE 5.

Total dietary vitamins C and E, ferric-reducing ability of plasma (FRAP), and the risk of glioma in the Health Professionals Follow-Up Study (HPFS; 1986–2004), the Nurses’ Health Study I (NHS I; 1980–2004), and NHS II (1991–2005)

Quintile of intake
1 2 3 4 5 P for trend1
Vitamin C (mg/d)2
 Cases 64 54 77 76 64
 Person-years 809,330 828,618 824,802 828,020 810,776
 RR (95% CI)3 1.0 0.77 (0.54, 1.12) 1.09 (0.78, 1.53) 1.05 (0.75, 1.47) 0.88 (0.62, 1.26) 0.67
Vitamin E (mg/d)2
 Cases 62 60 79 63 71
 Person-years 809,448 818,459 820,562 843,170 809,910
 RR (95% CI)3 1.0 0.93 (0.65, 1.34) 1.19 (0.84, 1.67) 0.91 (0.58, 1.42) 0.98 (0.67, 1.43) 0.72
FRAP (mmol/d)2
 Cases 66 80 56 66 67
 Person-years 805,989 824,369 831,714 830,220 809,256
 RR (95% CI)3 1.0 1.08 (0.71, 1.64) 0.76 (0.53, 1.09) 0.90 (0.63, 1.27) 0.90 (0.64, 1.28) 0.35
1

Based on the median value of each intake category and modeling these as continuous variables in a Cox proportional hazards model.

2

Cutoffs for quintiles were different for each cohort and are based on cumulative updated averages over the follow-up periods: vitamin C (HPFS: 155, 226, 364, and 696; NHS I: 138, 192, 279, and 500; NHS II: 119, 164, 233, and 428), vitamin E (HPFS: 11, 19, 64, and 164; NHS I: 9, 18, 53, and 160; NHS II: 9, 14, 26, and 117), and FRAP (HPFS: 9, 12, 14.5, and 19; NHS I: 9, 11, 13.5, and 17; NHS II: 7, 10, 12, and 15).

3

Rate ratios (RRs) and 95% CIs from Cox proportional hazards models were adjusted for age and caloric intake (quintiles). Results were obtained from pooling the β coefficient and SE estimates by using the DerSimonian and Laird random-effects model; no significant evidence of heterogeneity by cohort was observed (α = 0.05).

We observed no association with total meat, red meat, or processed meats when restricting the analyses to include only glioblastomas, which may be etiologically different from other gliomas. Furthermore, stratified analyses by age (<56 and ≥56 y) were similar to the overall findings.

DISCUSSION

In this study, we observed no association between meat or processed meat and risk of adult glioma. Furthermore, intake of nitrates and nitrites, which increase endogenous formation of nitrosamines, and intake of 2 preformed nitrosamines, were not related to glioma risk. Finally, there was no indication that individuals who eat processed meats but have a low antioxidant intake have a higher risk of glioma than do those who do not eat processed meats and have a high antioxidant intake.

With the exception of one cohort study, all studies to date have been case-control studies. In the cohort study, a detailed FFQ was used but only 21 cases of gliomas were identified after 6 y of follow-up (8). In this study, a relative risk of 2.3 was reported for intake of any pork products (including sausage, bacon, and ham) compared with never, but the relative risk was statistically unstable given the low case numbers. Of the 4 largest case-control studies (>200 gliomas in diet analyses), which included some assessment of meat intake (5154), 2 studies reported statistically significant 2- to 3-fold elevations in the risk of glioma for a high intake of cured meat or bacon compared with a low intake (51, 54). However, the excess risks were only observed among men and, in one study, reported relative risks were for high intake of cured meat combined with low fruit and vegetable intake (54). Of the 2 larger studies reporting no association for meat, it was not clear how meat intake was assessed in one study (52), and, in the second study, 76% of the data were obtained from proxy respondents (53). Among the smaller case-control studies, elevated risks have been reported for high consumption of bacon (55, 56) and meat and processed pork (57), but no associations were observed in other studies (5862).

Vitamins C and E inhibit nitrosation reactions in vivo, and intake of these vitamins can reduce the endogenous formation of NOC in the stomach (63). Epidemiologic studies have shown that consumption of vitamin C reduces the risk of gastric cancer (64), a tumor for which NOC may be a risk factor (65). To date, most epidemiologic studies of brain tumors have had limited dietary assessments and few questions that explored the relation between vitamin intakes and the risk of glioma. Of the 9 case-control studies with data on vitamin C intake from dietary sources and/or supplements, 2 studies reported statistically significant inverse associations with vitamin C supplement use (52, 58). In a third study, a relative risk of 0.2 was observed for ever use of vitamin C supplements, but this association was not statistically significant and vitamin C intake from foods was not related to risk (55). Vitamin C intake alone was not related to risk in another study, but, when combined with cured food intake, an interaction was observed such that men with a high cured meat intake and a low intake of foods rich in vitamin C had a 2-fold increase in risk compared with those with a low cured meat intake and a high intake of foods rich in vitamin C (54). The findings were similar but weaker among women (54).

The strengths of our study included its relatively large sample size, prospective design, detailed and updated information on different types of meats, and estimation of intake of nitrate, nitrite, and 2 common nitrosamines. The prospective design precluded recall bias, and selection bias was minimized by the very high rate of follow-up over a long period of time. As with any observational study on diet, measurement error is inevitable and may explain the lack of associations in the current study; however, we previously showed that dietary intake based on FFQs is well-correlated with food records in these cohorts, including for meat intake, and have reported associations with meat intake (including bacon) and cancer in these cohorts (66, 67). The repeated dietary measurements in these cohorts are important to account for changes in diet over long follow-up periods and to reduce measurement error; the analyses using the multiple dietary assessments did not alter our results. Another possibility was that the range of intakes for the different foods was not sufficiently large to detect an association; for example, we could not exclude the possibility that an association existed with meat intakes higher than those observed in these populations.

In these 3 cohort studies, we found no indication that total meat, total processed meat, nitrate, nitrite, or nitrosamine intakes were associated with risk of glioma. Similarly, we observed no relation with common antioxidants and risk of glioma or any effect modification between the 2 dietary exposures.

Acknowledgments

We thank Walter Willett for his valuable advice and Laura Sampson and Lauren Dougherty for creating the nitrite and nitrosamine database.

The authors’ responsibilities were as follows—DSM: contributed to the statistical analysis, interpretation of findings, and writing of the report; EG and DJH: contributed to data collection and funding; and CNH and TB: contributed to the interpretation and editing of the manuscript. None of the authors had any conflicts of interest.

REFERENCES

  • 1.Lijinsky W. N-Nitroso compounds in the diet. Mutat Res 1999;443:129–38 [DOI] [PubMed] [Google Scholar]
  • 2.Bogovski P, Bogovski S. Animal species in which N-nitroso compounds induce cancer. Int J Cancer 1981;27:471–4 [DOI] [PubMed] [Google Scholar]
  • 3.Bilzer T, Reifenberger G, Wechsler W. Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology. Neurotoxicol Teratol 1989;11:551–6 [DOI] [PubMed] [Google Scholar]
  • 4.Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995;93:17–48 [DOI] [PubMed] [Google Scholar]
  • 5.Cooper SF, Lemoyne C, Gauvreau D. Identification and quantitation of N-nitrosamines in human postmortem organs. J Anal Toxicol 1987;11:12–8 [DOI] [PubMed] [Google Scholar]
  • 6.Dietrich M, Block G, Pogoda JM, Buffler P, Hecht S, Preston-Martin S. A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control 2005;16:619–35 [DOI] [PubMed] [Google Scholar]
  • 7.Huncharek M, Kupelnick B, Wheeler L. Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 2003;22:129–37 [DOI] [PubMed] [Google Scholar]
  • 8.Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE. Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989;8:266–75 [DOI] [PubMed] [Google Scholar]
  • 9.Belanger CF, Hennekens CH, Rosner B, Speizer FE. The Nurses' Health Study. Am J Nurs 1978;78:1039–40 [PubMed] [Google Scholar]
  • 10.Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464–8 [DOI] [PubMed] [Google Scholar]
  • 11.Zhang SM, Willett WC, Hernan MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000;152:1056–64 [DOI] [PubMed] [Google Scholar]
  • 12.Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994;140:1016–9 [DOI] [PubMed] [Google Scholar]
  • 13.Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 1996;239:70–6 [DOI] [PubMed] [Google Scholar]
  • 14.Halvorsen BL, Holte K, Myhrstad MC, et al. A systematic screening of total antioxidants in dietary plants. J Nutr 2002;132:461–71 [DOI] [PubMed] [Google Scholar]
  • 15.US Assembly of Life Sciences, Committee on Nitrite and Alternative Curing Agents in Food The health effects of nitrate. Nitrite, and N-nitroso compounds. Washington, DC: National Academy Press, 1981 [Google Scholar]
  • 16.Andrzejewski D, Havery DC, Fazio T. Determination and confirmation of N-nitrosodimethylamine in beer. J Assoc Off Anal Chem 1981;64:1457–61 [PubMed] [Google Scholar]
  • 17.Biaudet H, Mavelle T, Debry G. Mean daily intake of N-nitrosodimethylamine from foods and beverages in France in 1987-1992. Food Chem Toxicol 1994;32:417–21 [DOI] [PubMed] [Google Scholar]
  • 18.Canas BJ, Havery DC, Joe FL, Jr, Fazio T. Current trends in levels of volatile N-nitrosamines in fried bacon and fried-out bacon fat. J Assoc Off Anal Chem 1986;69:1020–1 [PubMed] [Google Scholar]
  • 19.Fazio T, Havery DC, Howard JW. Determination of volatile N-nitrosamines in foodstuffs: I. A new clean-up technique for confirmation by II. A continued survey of foods and beverages. IARC Sci Publ 1980;31:419–33 [PubMed] [Google Scholar]
  • 20.Frommberger R. N-nitrosodimethylamine in German beer. Food Chem Toxicol 1989;27:27–9 [DOI] [PubMed] [Google Scholar]
  • 21.Havery DC, Fazio T, Howard JW. Survey of cured meat products for volatile N-nitrosamines: comparison of two analytical methods. IARC Sci Publ 1978;19:41–52 [PubMed] [Google Scholar]
  • 22.Hotchkiss JH. Preformed N-nitroso compounds in foods and beverages. Cancer Surv 1989;8:295–321 [PubMed] [Google Scholar]
  • 23.Lee JS, Libbey LM, Scanlan RA, Barbour J. N-Nitroso-3-hydroxypyrrolidine in fried bacon and fried out fat. IARC Sci Publ 1978;19:325–32 [PubMed] [Google Scholar]
  • 24.Massey RC, Key PE, Jones RA, Logan GL. Volatile, non-volatile and total N-nitroso compounds in bacon. Food Addit Contam 1991;8:585–98 [DOI] [PubMed] [Google Scholar]
  • 25.Meah MN, Harrison N, Davies A. Nitrate and nitrite in foods and the diet. Food Addit Contam 1994;11:519–32 [DOI] [PubMed] [Google Scholar]
  • 26.Miller BJ, Billedeau SM, Miller DW. Formation of N-nitrosamines in microwaved versus skillet-fried bacon containing nitrite. Food Chem Toxicol 1989;27:295–9 [DOI] [PubMed] [Google Scholar]
  • 27.Petersen A, Stoltze S. Nitrate and nitrite in vegetables on the Danish market: content and intake. Food Addit Contam 1999;16:291–9 [DOI] [PubMed] [Google Scholar]
  • 28.Scanlan RA, Barbour JF. N-nitrosodimethylamine content of US and Canadian beers. IARC Sci Publ 1991;105:242–3 [PubMed] [Google Scholar]
  • 29.Sen NP, Iyengar JR, Miles WF, Panalaks T. Nitrosamines in cured meat products. IARC Sci Publ 1976;14:333–42 [PubMed] [Google Scholar]
  • 30.Sen NP, Seaman S, McPherson M. Further studies on the occurrence of volatile and non-volatile nitrosamines in foods. IARC Sci Publ 1980;31:457–65 [PubMed] [Google Scholar]
  • 31.Spiegelhalder B, Eisenbrand G, Preussmann R. Volatile nitrosamines in food. Oncology 1980;37:211–6 [DOI] [PubMed] [Google Scholar]
  • 32.Spiegelhalder B, Eisenbrand G, Preussmann R. Occurrence of volatile nitrosamines in food: a survey of the West German market. IARC Sci Publ 1980;31:467–79 [PubMed] [Google Scholar]
  • 33.Stephany RW, Schuller PL. The intake of nitrate, nitrite and volatile N-nitrosamines and the occurrence of volatile N-nitrosamines in human urine and veal calves. IARC Sci Publ 1978;19:443–60 [PubMed] [Google Scholar]
  • 34.Stephany RW, Schuller PL. Daily dietary intakes of nitrate, nitrite and volative N-nitrosamines in the Netherlands using the duplicate portion sampling technique. Oncology 1980;37:203–10 [DOI] [PubMed] [Google Scholar]
  • 35.Tricker AR, Pfundstein B, Theobald E, Preussmann R, Spiegelhalder B. Mean daily intake of volatile N-nitrosamines from foods and beverages in West Germany in 1989-1990. Food Chem Toxicol 1991;29:729–32 [DOI] [PubMed] [Google Scholar]
  • 36.Walker EA, Castegnaro M, Garren L, Toussaint G, Kowalski B. Intake of volatile nitrosamines from consumption of alcohols. J Natl Cancer Inst 1979;63:947–51 [PubMed] [Google Scholar]
  • 37.Webb KS, Gough TA. Human exposure to preformed environmental N-nitroso compounds in the UK. Oncology 1980;37:195–8 [DOI] [PubMed] [Google Scholar]
  • 38.Ysart G, Clifford R, Harrison N. Monitoring for nitrate in UK-grown lettuce and spinach. Food Addit Contam 1999;16:301–6 [DOI] [PubMed] [Google Scholar]
  • 39.Ysart G, Miller P, Barrett G, Farrington D, Lawrance P, Harrison N. Dietary exposures to nitrate in the UK. Food Addit Contam 1999;16:521–32 [DOI] [PubMed] [Google Scholar]
  • 40.Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790–6 [DOI] [PubMed] [Google Scholar]
  • 41.Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114–26 [DOI] [PubMed] [Google Scholar]
  • 42.Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18:858–67 [DOI] [PubMed] [Google Scholar]
  • 43.Ascherio A, Stampfer MJ, Colditz GA, Rimm EB, Litin L, Willett WC. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J Nutr 1992;122:1792–801 [DOI] [PubMed] [Google Scholar]
  • 44.Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51–65 [DOI] [PubMed] [Google Scholar]
  • 45.Fritz AG. International classification of diseases for oncology: ICD-O. 3rd ed Geneva, Switzerland: World Health Organization, 2000 [Google Scholar]
  • 46.Willett WC. Nutritional epidemiology. New York, NY: Oxford University Press, 1990 [Google Scholar]
  • 47.Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro-oncol 2007;9:326–34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS. Prospective study of intake of fruit, vegetables, and carotenoids and the risk of adult glioma. Am J Clin Nutr 2007;85:877–86 [DOI] [PubMed] [Google Scholar]
  • 49.Willett WC. Issues in analysis and presentation of dietary data Willett WC, ed Nutritional epidemiology. 2nd ed New York, NY: Oxford University Press, 1998 [Google Scholar]
  • 50.DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88 [DOI] [PubMed] [Google Scholar]
  • 51.Giles GG, McNeil JJ, Donnan G, et al. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994;59:357–62 [DOI] [PubMed] [Google Scholar]
  • 52.Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. IARC Sci Publ 1991;105:197–203 [PubMed] [Google Scholar]
  • 53.Chen H, Ward MH, Tucker KL, et al. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 2002;13:647–55 [DOI] [PubMed] [Google Scholar]
  • 54.Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997;8:13–24 [DOI] [PubMed] [Google Scholar]
  • 55.Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 1997;8:5–12 [DOI] [PubMed] [Google Scholar]
  • 56.Ahlbom A, Navier IL, Norell S, Olin R, Spannare B. Nonoccupational risk indicators for astrocytomas in adults. Am J Epidemiol 1986;124:334–7 [DOI] [PubMed] [Google Scholar]
  • 57.Boeing H, Schlehofer B, Blettner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 1993;53:561–5 [DOI] [PubMed] [Google Scholar]
  • 58.Burch JD, Craib KJ, Choi BC, Miller AB, Risch HA, Howe GR. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987;78:601–9 [PubMed] [Google Scholar]
  • 59.Hochberg F, Toniolo P, Cole P, Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 1990;8:55–60 [DOI] [PubMed] [Google Scholar]
  • 60.Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992;51:20–7 [DOI] [PubMed] [Google Scholar]
  • 61.Kaplan S, Novikov I, Modan B. Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol. Am J Epidemiol 1997;146:832–41 [DOI] [PubMed] [Google Scholar]
  • 62.Hu J, La Vecchia C, Negri E, et al. Diet and brain cancer in adults: a case-control study in northeast China. Int J Cancer 1999;81:20–3 [DOI] [PubMed] [Google Scholar]
  • 63.Mirvish SS. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 1986;58:1842–50 [DOI] [PubMed] [Google Scholar]
  • 64.La Vecchia C, Franceschi S. Nutrition and gastric cancer. Can J Gastroenterol 2000;14(suppl D):51D–4D [DOI] [PubMed] [Google Scholar]
  • 65.Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996;23:281–91 [PubMed] [Google Scholar]
  • 66.Michaud DS, Holick CN, Giovannucci E, Stampfer MJ. Meat intake and bladder cancer risk in 2 prospective cohort studies. Am J Clin Nutr 2006;84:1177–83 [DOI] [PubMed] [Google Scholar]
  • 67.Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 1994;54:2390–7 [PubMed] [Google Scholar]

Articles from The American Journal of Clinical Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES